Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism. (Record no. 21585551)

MARC details
000 -LEADER
fixed length control field 01480 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516081538.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201205s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-6535
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/clpt.2011.269
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Liu, Y
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120508
245 00 - TITLE STATEMENT
Title Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical pharmacology and therapeutics
Date of publication, distribution, etc. Apr 2012
300 ## - PHYSICAL DESCRIPTION
Extent 660-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Black or African American
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aryl Hydrocarbon Hydroxylases
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytochrome P-450 CYP2C9
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genetic Variation
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hep G2 Cells
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Metabolic Clearance Rate
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polymorphism, Genetic
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Warfarin
General subdivision pharmacokinetics
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jeong, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Takahashi, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Drozda, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Patel, S R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shapiro, N L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nutescu, E A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cavallari, L H
773 0# - HOST ITEM ENTRY
Title Clinical pharmacology and therapeutics
Related parts vol. 91
-- no. 4
-- p. 660-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/clpt.2011.269">https://doi.org/10.1038/clpt.2011.269</a>
Public note Available from publisher's website

No items available.